Early PCa diagnosis mainly relies on prostate-specific antigen (PSA) tests, although this screening method exhibits several limitations as it is prostate-specific but not cancer-specific [3], leading to overdiagnosis and overtreatment [4,5,6]. This evidence concerns the gene PSAT1 and posterior cortical atrophy.